Activity

Filter

Cancel
Date Panel Item Activity
7 actions
Pulmonary Fibrosis_Interstitial Lung Disease v0.42 RPA1 Zornitza Stark Phenotypes for gene: RPA1 were changed from Bone marrow failure; T- and B-cell lymphopaenia; pulmonary fibrosis; skin manifestations; short telomeres to Pulmonary fibrosis and/or bone marrow failure, telomere-related, 6, MIM# 619767; Bone marrow failure; T- and B-cell lymphopaenia; pulmonary fibrosis; skin manifestations; short telomeres
Pulmonary Fibrosis_Interstitial Lung Disease v0.41 RPA1 Zornitza Stark edited their review of gene: RPA1: Changed phenotypes: Pulmonary fibrosis and/or bone marrow failure, telomere-related, 6, MIM# 619767, Bone marrow failure, T- and B-cell lymphopaenia, pulmonary fibrosis, skin manifestations, short telomeres
Pulmonary Fibrosis_Interstitial Lung Disease v0.40 RPA1 Zornitza Stark Marked gene: RPA1 as ready
Pulmonary Fibrosis_Interstitial Lung Disease v0.40 RPA1 Zornitza Stark Gene: rpa1 has been classified as Green List (High Evidence).
Pulmonary Fibrosis_Interstitial Lung Disease v0.40 RPA1 Zornitza Stark Classified gene: RPA1 as Green List (high evidence)
Pulmonary Fibrosis_Interstitial Lung Disease v0.40 RPA1 Zornitza Stark Gene: rpa1 has been classified as Green List (High Evidence).
Pulmonary Fibrosis_Interstitial Lung Disease v0.39 RPA1 Zornitza Stark gene: RPA1 was added
gene: RPA1 was added to Pulmonary Fibrosis_Interstitial Lung Disease. Sources: Expert Review
Mode of inheritance for gene: RPA1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: RPA1 were set to 34767620
Phenotypes for gene: RPA1 were set to Bone marrow failure; T- and B-cell lymphopaenia; pulmonary fibrosis; skin manifestations; short telomeres
Mode of pathogenicity for gene: RPA1 was set to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Review for gene: RPA1 was set to GREEN
Added comment: 4 individuals with gain of function variants with bone marrow failure, myelodysplastic syndrome, T- and B-cell lymphopaenia, pulmonary fibrosis, or skin manifestations reported.
Sources: Expert Review